Zobrazeno 1 - 10
of 19
pro vyhledávání: '"M. B. Vasudevachari"'
Autor:
Akram S. Shah, Julia A. Metcalf, Jorge A. Tavel, Chiung Yu Huang, Michael A. Polis, Robin L. Dewar, M. B. Vasudevachari, Joseph A. Kovacs, Jean Shen, Richard T. Davey, Henry Masur, Dean Follmann, Betsey Herpin, H. Clifford Lane
Publikováno v:
Journal of Interferon & Cytokine Research. 30:461-464
A randomized, controlled clinical trial was started in the pre-HAART era to compare the efficacy of zidovudine (AZT) and interferon-alpha (IFN-alpha) either alone or in combination to reduce HIV viremia, maintain CD4(+) cell count, and decrease time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b1d585280c8d7b6926d94c996f6553
https://doi.org/10.1089/jir.2009.0090
https://doi.org/10.1089/jir.2009.0090
Autor:
S E Haneiwich, Judith Falloon, Robert E. Walker, Robin L. Dewar, Richard T. Davey, M. B. Vasudevachari, J A Kovacs, Michael A. Polis, George F. Reed, Henry Masur
Publikováno v:
Proceedings of the National Academy of Sciences. 90:5608-5612
L-697,661 is a non-nucleoside analogue with potent, selective inhibitory activity against the reverse transcriptase of human immunodeficiency virus type 1 (HIV-1). The present study evaluated the potential role of this compound in the treatment of HI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ae9545bc27cd221c268b5e96713e6ee
https://doi.org/10.1073/pnas.90.12.5608
https://doi.org/10.1073/pnas.90.12.5608
Autor:
W.G. Tarpley, Jonathan Cook, N.P. Salzman, D.L. Romero, J.R. Palmer, M.C. Psallidopoulos, B. Zhao, H.C. Lane, M. B. Vasudevachari, C. Battista
Publikováno v:
Virology. 190:269-277
Certain bisheteroarylpiperazines (BHAPs) directly inhibit the replication of human immunodeficiency virus type 1 (HIV-1) and block the spread of infection to susceptible populations of cells. At a 1 μM concentration three analogs, U-87201, U-88204,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c563e87fa953c3c59b3a9edaa93236e
https://doi.org/10.1016/0042-6822(92)91213-e
https://doi.org/10.1016/0042-6822(92)91213-e
Autor:
M. B. Vasudevachari, Michael A. Polis, Robin L. Dewar, Julia A. Metcalf, Shyam Kottilil, Zonghui Hu, Helene C. Highbarger, H. Clifford Lane
Publikováno v:
Journal of clinical microbiology. 45(9)
This study compared two commercially available assays for the measurement of hepatitis C virus (HCV) RNA levels, the Bayer HCV RNA (version 3.0) branched DNA assay and the Abbott HCV analyte-specific reagent real-time PCR assay, to assess their quant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd7db521dbce0a76138b19fe8cdff701
https://pubmed.ncbi.nlm.nih.gov/17596352
https://pubmed.ncbi.nlm.nih.gov/17596352
Publikováno v:
Antimicrobial agents and chemotherapy. 40(11)
Patient human immunodeficiency virus type 1 (HIV-1) isolates that are resistant to protease inhibitors may contain amino acid substitutions L10I/V, M46L/I, G-48V, L63P, V82A/F/T, I84V, and L90M in the protease gene. Substitutions at positions 82 and/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc27a3f3b2d8ed5c7f8262ce1a571330
https://pubmed.ncbi.nlm.nih.gov/8913459
https://pubmed.ncbi.nlm.nih.gov/8913459
Autor:
R. L. Dewar, Richard T. Davey, M. B. Vasudevachari, H. C. Highbarger, John Todd, H C Lane, Mickey S. Urdea, M. D. Sarmiento, J A Kovacs, N P Salzman
Publikováno v:
The Journal of infectious diseases. 170(5)
A branched DNA (bDNA)-based quantitation of plasma human immunodeficiency virus type 1 (HIV-1) RNA was used to monitor the virologic status of 102 patients (29-906 CD4 cells/mm3) enrolled in clinical trials of antiretroviral and immune-based therapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2c67666664f16e8b8b823c5c02933cf
https://pubmed.ncbi.nlm.nih.gov/7963710
https://pubmed.ncbi.nlm.nih.gov/7963710
Autor:
Hoefheinz D, M B Vasudevachari, Woll Dr, N P Salzman, H C Lane, Mast C, Toedter G, K. W. Uffelman, Julia A. Metcalf
Publikováno v:
Journal of clinical immunology. 13(3)
The presence of p24 core antigen in the serum of individuals with human acquired immunodeficiency syndrome has been used as one of the important prognostic markers of HIV-1 infection and also as an end point in evaluating antiviral drugs and vaccines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b5e6f7d2434b9eb6b4660eca9b9df7c
https://pubmed.ncbi.nlm.nih.gov/8100572
https://pubmed.ncbi.nlm.nih.gov/8100572
Publikováno v:
Journal of acquired immune deficiency syndromes. 5(8)
HIV-1-specific antibodies have been detected in the saliva of seropositive individuals and may play a role in preventing oral transmission of the virus. We have analyzed saliva samples obtained from HIV-1-seronegative individuals who were immunized w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::81acb5941f9aa53f8ad881162d1e25c9
https://pubmed.ncbi.nlm.nih.gov/15346543
https://pubmed.ncbi.nlm.nih.gov/15346543
Publikováno v:
AIDS research and human retroviruses. 6(3)
The detection of HIV-1 in human peripheral blood lymphocytes is routinely carried out by cocultivation of test cells with normal peripheral blood mononuclear cells (PBMC). The presence of virus is evidenced by cytologic observation of syncytia or by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b766bb9d1af5671a6ea4facdaf5d951
https://pubmed.ncbi.nlm.nih.gov/1692726
https://pubmed.ncbi.nlm.nih.gov/1692726
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 5:817
HIV-1-specific antibodies have been detected in the saliva of seropositive individuals and may play a role in preventing oral transmission of the virus. We have analyzed saliva samples obtained from HIV-1-seronegative individuals who were immunized w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44c2acdfcd7c7f041f18ee24d02ba555
https://doi.org/10.1097/00126334-199208000-00008
https://doi.org/10.1097/00126334-199208000-00008